Amipizone
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161530This classification denotes a phosphodiesterase inhibitor with the molecular formula C14H16ClN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7OT95Q2G4E, chemically known as 6-(p-(2-chloropropionylamino)phenyl)-5-methyl-4,5-dihydropyridazin-3-one but generally known as amipizone, which bears US NIH Compound Identifier 68889. European Medicines Agency schedules Amipizone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05454MIG. The term AMIPIZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). AMIPIZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amipizone under HS 29339990 and SITC 51577. As of Q4 2014, AMIPIZONE remains the US FDA Preferred Term for this commodity. Amipizone bears US NLM identifiers UMLS ID C2698092 and NCI Concept Code C74345. SMILES: CLC(C(=O)NC1CCC(C2=NNC(=O)CC2C)CC1)C.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.